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Objectives: To assess the incidence, prevalence and consequences of illness in one 
professional academy rugby league club during an in-season period. 
Design: Observational prospective cohort study. 
Method: Seventeen male rugby league players (age 17.7 ± 0.7 years, stature 178.8 ± 5.1 cm, 
body mass 87.2 ± 9.6 kg) completed a weekly self-report illness questionnaire using an 
amended version of the Oslo Sports Trauma Research Centre (OSTRC) questionnaire on 
health problems. 
Results: A total of 24 new illnesses were reported over the 25-week study period. 65% of 
players experienced at least one illness during the study. The incidence of illness in this cohort 
was 14.3 per 1000-player days, with the respiratory system being most commonly affected (n 
= 15; 62.5%). The average weekly illness prevalence was 10.3%. Time-loss illness incidence 
was 1.4 per 1000-player days. Loss of body mass and sleep disruptions were the most 
commonly reported consequences of illness episodes. Mean body mass loss during a period 
of illness was 2.2 ± 0.6 kg. 
Conclusions: Academy rugby league players are most commonly affected by respiratory illness 
with a total of nineteen training and competition days lost to illness. Associated consequences 
of illness, such as loss of body mass and sleep disruptions may present a challenge and 
negatively impact a rugby league player’s development. Appropriate medical provisions should 
be provided for Academy rugby league players to provide support during periods of illness to 
limit the impact of these consequences.  
 
 




Illness in athletes can be detrimental to health and performance, resulting in a possible 
reduction in/of performance and time-loss from training and competition 1. Increased training 
loads, regular travel, poor nutrition, reduced sleep and lack of appropriate hygiene practices 
may all contribute to increased risk of illness 1, 2. Due to their close-proximity to team mates 
and other athletes, team-sport athletes may experience an increased risk of illness 3, 4. In 
particular, rugby players may experience an increased susceptibility to illness and infection 
due to the unique contact demands experienced training and during match-play, including the 
strenuous physical nature and frequent skin to skin contact 4-6. 
 
Much of the illness monitoring research within rugby focuses on rugby union, with studies 
dating back as early as 1979, assessing scrum-pox and methicillin resistant Staphylococcus 
aureus (MRSA) 7, 8. More recent research has assessed illness in rugby union during both 
training and competition periods 9-11, identifying that players experience an incidence of 20.7 
illnesses per 1000-player days 9 with 92% of all players suffering from at least one upper 
respiratory illness (URI) over a season 11. Illness monitoring in rugby league has received little 
attention, with only a limited number of studies published to date 2, 12, 13.  
 
Rugby league provides a unique population due to the high-intensity bouts and frequent 
collisions 14, as well as the sport’s winter pre-season and summer in-season (when played in 
the Northern Hemisphere) potentially exposing players to a variety of temperature and 
environmental extremes. Previous illness monitoring research in rugby league has identified 
an average incidence of 1.4 illnesses per player per season 12, however research has 
predominantly focused on full-time professional players and is yet to be undertaken within 
Academy cohorts. Academy (i.e., Under 19s age group) rugby league players are typically 
part-time adolescent players who are challenged with balancing compulsory education, 
professional rugby, adolescent growth and high-training loads to drive adaptation and physical 
development 15. Additionally, many Academy rugby league players struggle to meet basic 
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dietary requirements for these physiological demands 16, therefore, players may experience 
an elevated risk of illness. Due to the importance of physical development for these players 17, 
18, illness may be of increased concern due to potential consequences such as; physical 
implications (i.e., lack of sleep and loss of body mass), availability for squad selection and 
time-loss from training 11, 19. Previous research has identified that athletes who sustain two or 
more illnesses in a season are three times less likely to achieve their goals than those who 
sustained fewer 20.   
 
To the authors’ knowledge, no studies to date have assessed illness incidence or prevalence 
in Academy rugby league players. Furthermore, the consequences of illness in this population 
remain unknown. Therefore, the aim of this study was to assess the incidence, prevalence and 




An observational prospective cohort study was conducted to investigate the incidence, 
prevalence and consequences of illness in Academy (i.e., Under 19s) rugby league players 
during the 2018/19 in-season period (April to September 2019). 
 
Seventeen male rugby league players (age 17.7 ± 0.7 years, stature 178.8 ± 5.1 cm, body 
mass 87.2 ± 9.6 kg) participated in the study. Participants were recruited from one English 
Super League Academy squad. All participants were made aware of the benefits and 
perceived risks of the study and provided written informed consent. Ethics approval was 
granted by Leeds Beckett University Ethics Committee (no. 57455). 
 
Participants completed a weekly self-report illness questionnaire using an amended version of 
the Oslo Sports Trauma Research Centre (OSTRC) questionnaire on health problems 21. The 
OSTRC questionnaire on health problems is adaptable to a wide variety of sports and monitors 
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self-reported outcome measures of the symptoms, severity and impact of illness 22. Validated 
in elite athlete cohorts and developed from the validated OSTRC overuse injury questionnaire 
23, the questionnaire has the potential to form a model that could be used for athlete monitoring 
across a wide variety of sports 22.  
 
An adapted version of the International Olympic Committee’s (IOC) definition of illness was 
used for this study: “a new or recurring symptomatic illness that was incurred during 
competition or training, which either received medical attention or was self-reported by the 
player, regardless of the consequences with respect to absence from competition or training” 
1. For the purpose of this study, subclinical immunological precursors of symptomatic illness 
were not measured. 
 
Participants completed the questionnaire at afternoon training (4pm), on the same day 
(Thursday), once a week, using an online Google document (Google Forms, Google, CA, 
USA), alongside their pre-existing wellness monitoring. Participants were asked to report 
information about illnesses they had been experiencing over the past week, including 
reoccurring illnesses (illnesses affecting the same body system which were reported across 
two reporting periods) and were able to report up to five different illnesses each week. 
 
The amended version of the OSTRC questionnaire consisted of four key questions (Figure 1) 
and six additional questions; injury was removed for the purpose of this study. The 
questionnaire asked participants about the impact of illness on their sport participation, training 
volume, performance and severity of symptoms experienced during the previous seven days 
21, 24. If the participant reported that there had been no impact on any of the four key questions 
(i.e. full participation without illness / no training / performance reduction / no symptoms), the 
questionnaire was finished for that week 21. If, however, participants answered anything other 
than “no illness / impact” on any of the four key questions, they were directed to answer 
additional questions. Participants could report multiple symptoms for the same illness and any 
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time lost in days; this was defined as a loss of one or more training or match days 9. Time-loss 
was confirmed by the lead researcher for accuracy in the participants’ reporting. A full copy of 
the questionnaire can be found in online supplementary material one. 
 
<Insert Figure 1 near here> 
 
For the purpose of this study, an open-ended question was added to identify any additional 
consequences of the reported illness. Fasted body mass was collected twice a week as part 
of the participants’ standard practice. Players followed the same protocol, including using the 
same scale, being in a fasted state post urine void, first thing in the morning for every weigh 
in. Education was provided to players to ensure they measured their body mass in the correct 
way. When a player reported as ill, the change in body mass during this period was reported. 
Participants with illnesses of major concern or those which presented for more than 4-6 weeks 
were referred to the club doctor by the sports science department (i.e., physiotherapist/sports 
scientist/nutritionist). As outlined in previous literature, similar illnesses reported in close 
proximity to each other were treated as a single case for incidence analysis purposes 23, 24. 
 
Illnesses were coded by symptoms and body system affected 21 using the International 
Classification of Primary Care, V.2 (ICPC-2) by the lead researcher and a medically trained 
physician. 
 
Data from the first week of collection were excluded from all calculations due to potential over-
reporting, as previously recommended 23. Descriptive data are presented as mean ± SD. 
Prevalence was defined as the proportion of the study population that had cases of illness 
each week 25; an average weekly prevalence was calculated. Prevalence was calculated by 
dividing the number of participants reporting an illness by the number of questionnaire 
respondents for that week 21. Prevalence of substantial impact illnesses was also calculated 
and was defined as illnesses which lead to reductions in training volume and performance, 
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either moderate or severe, as well as complete inability to participate in training or competition 
21. 
 
Illness incidence was defined as the rate at which new cases of illness occurred in the study 
population during a specified period 25. Illness incidence per 1000-player days and time-loss 
illness incidence per 1000-player days were calculated. Prevalence and incidence measures 
were presented as weekly averages with 95% CI.  
 
Severity scores, including weekly, average weekly and cumulative, were calculated for each 
illness and body system affected using methods previously outlined 23. The cumulative severity 
scores for all illnesses were summed, and the proportion of the total number made up by body 
systems affected was determined to estimate the relative burden of different types of illnesses. 
Answers to the open-ended question regarding consequences of illness were checked for 




Participants had 100% compliance for questionnaire completion. During the 25-week study, a 
total of 2975 player days were assessed (training; n = 1394, rest; n = 1292 and competition; n 
= 289). Participants competed in 17 competitive fixtures, as part of the Super League under 
19s Academy Championship.  
 
A total of 24 new illnesses were reported over the 25-week study period. Just under two thirds 
(65%) of players experienced at least one illness during the study. This resulted in a mean 
incidence of 1.4 illnesses per player. The most commonly affected body system was 
respiratory (n = 15; 62.5%), followed by digestive (n = 5; 20.8%) and skin (n = 4; 16.7%). The 
most common symptoms reported were blocked nose / running nose / sneezing (n = 9) and 




The total incidence of illness was 14.3 per 1000-player days (95% CI; 9.6 to 21.3). The average 
weekly illness prevalence was 10.3% (95% CI; 9.3 to 11.4%). In 63% of illnesses (n = 15), 
athletes reported no time-loss days or training volume reduction but continued to train despite 
suffering from an illness. 
 
Eight time-loss illnesses were reported with a total of 19 days lost to illness (mean and SD; 2.4 
± 1.8 days), with six days being the greatest amount of time lost due to a respiratory system 
illness. One in three illnesses resulted in time-loss, with time-loss illness incidence accounting 
for 1.4 per 1000-player days (95% CI; 0.7 to 2.8). The amount of time lost was greater from 
respiratory system illness (n = 12 days; 63%) compared to digestive system (n = 7 days; 37%). 
No time was lost to skin complaints. 
 
The relative burden of body systems affected was calculated using the cumulative severity 
score. The respiratory system was the highest burden (49%), followed by skin (27%) and 
digestive system (24%). The most commonly reported consequence of illness was loss of body 
mass (n = 4). The mean body mass loss from all athletes during a period of illness was 2.2 ± 
0.6 kg. Sleep disruption was also reported (n = 3). One player was unable to compete in match-
play due to illness despite being selected for the team. 
 
<Insert Figure 2 near here> 
 
Discussion 
This study aimed to assess the incidence, prevalence and consequences of illnesses in one 
professional academy rugby league club during an in-season period. To our knowledge this is 
the first study in rugby league to establish incidence and prevalence, as well as the additional 
consequences of illness, including loss of body mass and disrupted sleep, which may hinder 
athletic development in Academy players. This information can be used to better support 
10 
 
athletes during periods of illness, including additional nutrition support to prevent excessive 
body mass loss and education of sleep hygiene protocols. In agreement with previous research 
at the senior level in rugby league 2, 12, as well as across illness surveillance within elite 
international rugby 1, the findings show the most common body system affected by illness was 
the respiratory system.  
 
In the current study, the average illness incidence was 1.4 illnesses per player during the 
investigation period. These findings are similar to previous research undertaken at the senior 
Australian level where illness accounted for approximately 1.4 illnesses per player (45 illnesses 
in 32 players), albeit over a 29-week pre-season and competition period 12. When split by 
playing teams however, illness incidence was greater in National Rugby League (NRL) players 
(1.94 illnesses per player) compared to New South Wales cup players (0.83 illnesses per 
player) 12. As previously suggested, rugby league players may experience greater illness risk 
as playing level increases due to increased stressors 12, however further research is required 
to examine this. An additional limitation of the current study is the lack of non-athlete age-
matched cohorts. Inclusion of a control sample would have provided greater understanding of 
the impact of illness. Previous studies have assessed elite adolescent athletes’ illness 
prevalence compared to sub-elite age matched cohorts. One study reported slightly greater 
weekly prevalence of illness (14%) in sub-elite athletes compared to elite athletes (12%) 24 and 
previous research has suggested that sport participation could be protective and reduce the 
risk of illness in athletes 1. 
 
Illness incidence findings in the current study (14.3 per 1000-player days) are lower than 
previous research undertaken in rugby union, during an international competition (20.7 per 
1000-player days) 9. This could be due to the competition period that was assessed, which 
may have resulted in higher match frequency, increased exposure to other players and 
possibly greater exposure to pathogens, due to frequent air travel, which has been shown to 
increase risk of illness by 2 – 3-fold 10. On the contrary, the current study showed greater time-
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loss illness incidence (1.4 per 1000-player days [95% CI; 0.7 to 2.8]) compared to senior 
professional rugby union players (0.8 per 1000-player days) over two full seasons 26.  Despite 
this difference, it should be acknowledged that time lost from illness may not pose as great a 
burden to Academy rugby league players as time lost from injury. Previous research within this 
cohort identified that one injury results in greater time-loss (22 ± 19 days on average) 
compared to illness (2.4 ± 1.8 days). Academy rugby league players anecdotally receive less 
medical support than professional full-time players. Appropriate medical provisions should be 
provided for Academy rugby league players to provide support during periods of illness to limit 
the impact of these consequences.  
 
Throughout this study, many athletes continued to train despite suffering from an illness and 
thereby experienced no time-loss or training volume restriction (n = 15). Skin complaints were 
one of the most common complaints that athletes continued to train with and accounted for 
16.7% of all illnesses. The percentage of all skin complaints in this study is in line with that of 
Cross 26 who reported 20% proportion of illness from skin complaints in a professional rugby 
union team. However, research undertaken over a 20-week in-season period in female youth 
soccer players found athletes did not report any skin complaints 27. Due to the contact nature 
of rugby, it is hypothesised that the confined environment and frequent player-to-player contact 
may increase the risk and rate of skin complaints in this population 9. Furthermore, exposure 
to soil and dirt, as well as inconsistent covering of skin complaints may have increased 
transmission between players. Exclusion from match-play is suggested for those who do not 
cover skin complaints appropriately 4, i.e. using medical tape. 
 
A further novel aspect of this study was the assessment of consequences of illness in this 
cohort. Loss of body mass was the most commonly reported consequence during an illness, 
with a mean loss of 2.2 ± 0.6 kg during an illness episode. Long-term improvements and 
changes in body mass and strength are required by Academy rugby league players between 
the ages of 16 to 20 years old, to help players progress through the development pathway 19. 
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Collective loss of body mass at this time, caused by frequent illness episodes, could limit a 
player in their long-term development. Additionally, sleep disturbances were also reported as 
a consequence of an illness episode. It has been hypothesised that sleep disturbance could 
result in decline of both short-term recall and working memory performance, which may impact 
rugby league players who require tactical awareness for set match-plays 28. 
 
While this study provides practical data, it is important to consider that this study did not assess 
the multifactoral stressors that may influence illness, such as, immune markers, nutritional 
intake and training load, which may have identified periods of increased risk of illness. 
Furthermore, another limitation of this study is the lack of physical examination and diagnosis 
at the time of the illness. As athletes were only required to self-report symptoms, the incidence 
of illnesses may have been over estimated and recall bias may have resulted in inaccurate 
reporting. Symptoms of URI can mimic that of inflammation or allergy 1, however contrary 
evidence suggests that athletes and general population (controls) are able to accurately 
diagnose symptoms of upper respiratory tract infection (URTI) in 94% of cases when 
diagnosed by a physician 29, 30. An additional limitation of the study is the small sample size 
which may limit generalisation of results to the wider rugby league population and may be 
inherent to this rugby league training environment. 
 
Conclusion 
Academy rugby league players are most commonly affected by respiratory illness with a total 
of nineteen training and competition days lost to illness. A total of 24 new illnesses were 
reported over the 25-week study period, with an average illness incidence of 1.4 per player. 
Illness incidence accounted for 14.3 illnesses per 1000-player days, with time-loss illness 
accounting for 1.4 illnesses per 1000-player days. In conclusion, illness may present a 
challenge to Academy rugby league players due to the associated consequences which may 
negatively impact a rugby league player’s development, however it is acknowledged that injury 
remains the greatest contributor to time lost from training and competition. Appropriate medical 
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provisions should be provided for Academy rugby league players to provide support during 
periods of illness to limit the impact of these consequences. 
 
Practical Implications 
This study provides important considerations for those working within youth sport requiring 
physical development through player pathways. 
• Athletes and practitioners should be aware of the consequences of illness episodes, 
such as loss in body mass and sleep disturbances, which may impact long-term 
development. 
• Practitioners should ensure athletes are appropriately supported during illness 
episodes to reduce time-loss from training. 
• Skin complaints should be suitably covered as athletes regularly continue to train and 
play whilst suffering from these. 
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Figure 1 – The four key questions from the adapted weekly online Oslo Sports Trauma 
Research Centre (OSTRC) questionnaire on health problems 21 
 
Figure 2 – Weekly prevalence of all illnesses across the 25-week study (filled bars). Weekly 
prevalence of substantial illnesses across the 25-week study (clear bars). 
 
